The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The company intends to file an IND submission by the end of this year and begin clinical studies in 2027
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
Next-generation berberine formulation developed with BioSOLVE Technology targets metabolic health, blood sugar balance, and weight management
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
Antiviral injection addressing CMV and HSV infections had US market sales of nearly $15 million in the last 12 months
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
